Injecting Mounjaro Every 5 Days: What the Schedule Actually Says

Mounjaro's licensed dosing interval is once every seven days — the trials and the safety profile are grounded in that rhythm.
A five-day interval is shorter than licensed, which means the dose arrives earlier than the body's usual clearance window; this can affect both tolerability and efficacy.
If you've missed a dose or need to adjust timing, the Patient Information Leaflet and your prescriber are the right reference points, not an adjusted personal schedule.
Changes to your injection schedule are a clinical decision; raise any timing questions with your prescriber before acting on them.

Mounjaro (tirzepatide) is licensed as a once-weekly injection, meaning a seven-day gap between doses is the schedule the clinical evidence is built on. Injecting every five days shortens that interval and steps outside the licensed regimen — something a prescriber needs to weigh in on before you change anything. The urge to adjust timing is understandable: a missed day here, a bout of nausea there, and suddenly the maths stops feeling so clean. But the seven-day cycle isn't arbitrary. It reflects the pharmacokinetics of tirzepatide (how long the active compound stays at effective levels in the body) and the safety data gathered during trials involving thousands of adults. Mounjaro is a prescription-only medicine, so any question about dosing frequency is one for the clinician who holds your prescription, not a judgement call to make alone. The NHS patient information for tirzepatide confirms the once-weekly schedule as the standard.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How the seven-day interval works, and what happens when it shifts

Step 1: Understand why seven days is the number

Tirzepatide has a half-life of roughly five days, which means it takes about that long for the concentration in your body to halve. The once-weekly schedule is chosen so that levels stay high enough to be effective while not accumulating to a point that increases side effects. Clinical trials (including SURMOUNT-1, published in the New England Journal of Medicine) were run on this exact schedule. The average weight reduction of around 20–21% at the highest dose is a result tied to that protocol, not to a faster cycle.

That half-life detail matters practically. If you inject on day five instead of day seven, you're adding a new dose when the previous one is still at a relatively high level. Over several weeks, that compressed schedule can push blood levels higher than the trials tested. Higher isn't automatically better, it's more likely to mean more nausea, more vomiting, or other gastrointestinal side effects during a period when you're already adjusting.

One common misconception is that injecting slightly earlier will produce faster results. The evidence doesn't support that, and our guidance on whether you can inject tirzepatide every five days explains in more detail why a shorter cycle doesn't accelerate progress. Tirzepatide works over weeks and months; shaving two days off one cycle won't change your trajectory but could make the next week harder to get through.

Step 2: What the SmPC says about flexibility

The Mounjaro Summary of Product Characteristics (SmPC) on the eMC does allow one narrow exception to strict weekly timing: if you miss a dose, you may inject it within four days of the missed day. After that four-day window, skip the missed dose and return to your usual schedule. That's not an invitation to routinely inject on a shorter cycle, it's a recovery provision for genuine lapses.

Outside that missed-dose window, the SmPC is clear: resume on your original weekly day and continue from there. There is no provision in the licensed guidance for a standing five-day or six-day cycle. If your lifestyle makes a fixed weekly day genuinely difficult, the right conversation is with your prescriber about finding a day that works consistently, not adjusting the interval yourself.

Our clinical team at nume reviews each patient's dosing history before any repeat prescription; changes to the schedule that fall outside the licensed guidance would be picked up at that point.

Step 3: What to do if your timing has drifted

Timing drift is more common than people expect. Life intervenes (travel, illness, forgetting which day was last) and before long the gaps vary between five and nine days. A question that comes up regularly in this context is whether Mounjaro should be injected every day, and the short answer is no, it's a once-weekly medicine. The practical fix is to pick a fixed weekly day, mark it somewhere visible, and treat it like any other recurring appointment.

If you've already injected on a shorter cycle and you're wondering whether to correct back, speak to your prescriber before your next dose. They can look at when you last injected and advise on the safest way to re-establish the weekly rhythm. Some people find that questions like this come up between their regular check-ins; getting in touch with the support team is the right first step rather than trying to work it out alone.

For related questions about spacing (including what happens at the other end of the window) there's more detail on injecting every six days and on injecting every four days, both of which involve different considerations.

Where to find accurate timing support

Your Patient Information Leaflet is the most precise reference for day-to-day questions about timing and missed doses. It's included in every Mounjaro box. If you've mislaid it, the full version is available via the eMC. The NHS tirzepatide page also covers what to do if a dose is late or forgotten in straightforward language.

For anything that feels like a clinical decision rather than a factual lookup (including whether can you inject tirzepatide every five days as an adjusted schedule) that belongs with a prescriber. You can learn more about how Mounjaro injections work in practice, including injection sites and technique. There's also a fuller overview of tirzepatide as a weight-management medicine if you're still building the picture.

If you're thinking about starting treatment or reviewing whether your current plan is right for you, checking your eligibility with our prescribers is the place to begin. Consultations are free, reviewed by a GPhC-registered Independent Prescriber, and there's no obligation to proceed.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions